Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sounds good Livendi, I hope you are right about IND. I think the second of the staggered runs will help ensure an accepted IND, if successful.
Agree, and thats the way it should be, only real progress should move this stock. I have been here long enough to see people congratulating each other and then see things go sour. I am hoping their plan is to release news on a submitted IND before the December CC.
lower than the big biz show, thats pretty low. I don't feel that way. Hopefully we will get
solid news soon enough.
Jklm, I think PR’s like this are written for those just introduced to the stock. I guess that’s a pump. I know we are waiting for hard news and the pr had none. They are trying to gain attention before IND( unicorn) is submitted. Hope all is well with everyone. Go PMCB!
Thank You! GO PMCB!
Fine examples all, but I still don't want to change CEO at this point in time. Its all about the IND. Once we have an accepted IND everything will fall into place.
So right as we are about to file the IND for PC some here want to change leadership. I wouldn't change managers right before the world series is about to start.
Mr Waggoner is an old man. He is at the end of his career. He is not going to take a pay cut at the end of his career.
Changing CEO's now will just delay the IND. I don't think you all need to worry about the CEO. This is his swan song.
My guess is we will become part of a larger entity and the current CEO will retire, if not someone will take over.
I agree the runs have to match. I believe that Judd's involvement has solved any problems with the manufacturing runs.
This is why the need to fully document all failures, so the FDA has all the info. This was stated I believe in the conference call. That base has been covered.
Redoocs, I did not receive the last message you sent to me. Good luck, I hope you are successful in whatever it is you are doing. Lets Go PMCB! IND coming soon!
My Hanky stocks are going through the roof theses days.
https://ir.pharmacytebiotech.com/press-releases/detail/212
“The efforts undertaken to meet this milestone were monumental and involved everyone associated with the technical aspects of the manufacturing process. We cannot be more thankful to our colleagues at Austrianova and those from PharmaCyte who were involved in the work. I feel strongly that we’re back on track to completing both of the required manufacturing runs that will generate the data needed to complete the IND.”
Exactly Coastal Exactly. What is the need to get upset? Roll with the punches and don't invest more than you can afford.
I agree with you esusan, we are going to get a deal.
RC, it's market days like today I buy stock.
Sounds good, I am waiting. I don't fear missing out, there are always opportunities. Good luck my friend!
I think we have 2 years here before profitable.
I will get back in at $12. Just my opinion not investment advice.
https://www.marketwatch.com/story/cannabis-stocks-tumble-as-analyst-tells-investors-to-brace-for-more-weak-earnings-2019-10-02
I agree about IND, might not happen until Q1 2020.
Now A2Z weren't you the one saying you wanted to hear judd's perspective. Why won't KW let Judd talk? Here he is giving his opinion like you wanted. Not a Carrot this time. Judd would not put his reputation on the line unless he thought it was good. It's good news.
I have been trading equities for 45 years!
Tilray is still way overvalued.
Some of Thermo Fisher's recent acquisitions:
TF acquires Pantheon Inc for 7.2 billion
TF acquires FEI Co for 4.2 billion
TF acquires Affymetrix Inc for 1.3 billion
TF acquires Life Technologies for 13.6 billion
TF acquires Brammer Bio for 1.7 billion
I guess the market has not digested the news yet. LOL
My chart is showing the golden sunglasses formation. Which means I will be on the beach catching rays after the IND is filed.
I have the same average Jodi1, Good luck to us, and I agree. I was going to ask if these guys were all planning on selling at .04.. What is with .04. Wake me at 20cents..
Whats the chart say? LOL
No bottom yet, still going down.
I hope you get your .06's so you can take care of business. I am going to stay in and risk it. That's what it is a risk. If you didn't invest too much its not much of a risk, and the potential reward is huge.
Good luck to you!
Once the IND is filed we will be in a new trading range. It's anyones guess what that will be.
I would expect funding news soon there after. There will be more eyes on the stock and it will react to positive news.
Patents should be completed soon which is another biscuit to drive up the stock.
What happens when we enroll our first patient? The stock will move.
After the first patient is enrolled we wait for the preliminary results. If results are positive then again we move to a new trading range.
If we get any inkling of positive results that is when I would like see KW sell us out to the highest bidder.
Yes that was fun but I think that once the trial starts we will be beholden to some other entity that funds us and the buyout deal will already be in place if trial is successful. Most likely scenario IMO.
And of course we could run out of money or trial could fail but if you do your DD you might find as I did that this dog has a chance to hunt. I am gullible to the end or I made a good investment. Soon we will know.
Ferrisb, I think some investors are jealous that you have the huevos for this investment and they don't. Many longs here who are not afraid have your back. Good luck to us.
Unfortunately this stock will do nothing but drift down until IND is filed. NOTHING accept an IND is going to move this stock. Reality
I had unexpected company show up during the call. I was interrupted as KW was telling us what went wrong with runs.
If people picked up on potential partner on the CC by what was not said, I believe them.
IND opens doors
CC
I am disappointed that the value of my investment is not rocketing next week.
We are making progress, just not as quick as everyone here would like.
Certainly not selling any shares.
Future here looks bright except for one problem. $ . The longer this drags on, the more PMCB needs. The more dilution we experience.
A partnership could alleviated the money concern. Where is the news on that?
back at you ferenc with the respect. i agree i hope we get that info as well
typing one handed(left) so cut me some slack. So, I am a gullible bag holder, who is not making any friends amongst other gullible longs by mentioning a RS all the time. never been the clique type.
i am holding all my shares. i am also not the panic type.
hoping for good news on IND. after a successful trial for LAPC, then i will get excited about other treatments (diabetes), but not before.
would also like partnership/funding news
GLTA
I hear your points and A2Z's as well.
The opinions of many against our CEO are so frequently posted that perhaps many are poked into being fired up. It then becomes a narrative that is repeated and carried on.
I was just throwing out another possibility. Offering some balance. You know I get angry at the company sometimes.
I have been invested in PharmaCyte for over four years now. I was here for the pre-IND meeting. I was here for the Italian Job. I was here for "we are there".
I will tell you that I really have not for a moment thought this was a scam OR that our CEO is disingenuous. KW appears sincere in his desires to help people. He gets paid the big bucks because the task he has been given is difficult.
Trying to grow our cell banks in Italy was KW's biggest mistake. As a business man I can see that it is good to outsource labor to get things done cheaper. This is a great strategy if you are assembling widgets but not for something as sensitive as growing cells. In this case it was Italy's strange regulatory environment that got us.
Boy did these executives learn from that mistake. Since we started doing business with Eurofins there has been nothing but steady progress going forward.
"We are There", This really did upset me personally. This statement means different things to different people. To a geologist this could mean the Holocene (the last ten thousand years). To an investor this means the next trading day. I believe he was trying to tell us that we are close, but he himself did not realize how many tests there were and how long it would take. He, like myself, is not a biologist. Like one of my colleagues always says "Don't ask the janitor to find the square root of something". KW is out of his element when setting timelines for biologics.
Sometimes I appear negative. I am just realistic. When I see 1.3billion shares outstanding and a PPS of less than 4cents my mind immediately goes to reverse split.
I want the IND. That gives us so much more credibility. I sincerely hope we get positive news about the soon to be filed IND.
Other good news is possible. If we enter into a Joint Venture with a notable company such as Thermo Fisher we also gain credibility and access to far more resources. This would be great news too.
Sorry for the defense of KW. I know most of you are not fans. Just giving my thoughts. GLTA
Sorry you are leaving, always read your posts, great DD.
PMCB has stopped answering my questions via email. My last email suggested they suspend their salaries until the IND was filed. No response.
After a quick preview of companies, I thought Medexus Pharma was a good candidate. But what do I know?
Medexus Pharma, based in Chiago. From their website:
Partnering with Medexus Pharma, Inc.
"Medexus Pharma, Inc. believes that through collaboration, multiple vantage points are explored, new perspectives are forged, and ultimately, complex problems are solved. For this reason, we continually seek strategic partnerships with companies that, like us, are striving to develop innovative medicines that improve the longevity and quality of human lives.
We are focused on acquiring, developing, and commercializing mid- to late stage molecules, as well as in in-licensing and co-promoting currently marketed products centered on autoimmune disease, oncology, and other niche therapeutic areas."